Trial · NCT05040971
Outcomes17
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Body Weight (Percentage [%]) | From randomisation (week 0) to end of treatment (week 52) | Full analysis set (FAS) included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Percentage (%) of body weight | MEAN |
| PRIMARY | Participants With Change to Normoglycemia | At week 52 | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Change in Glycosylated Haemoglobin (HbA1c) | From randomisation (week 0) to end of treatment (week 52) | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Percentage of HbA1c | MEAN |
| SECONDARY | Change in Fasting Plasma Glucose (FPG) | From randomisation (week 0) to end of treatment (week 52) | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | millimoles per liter (mmol/L) | MEAN |
| SECONDARY | Change in Waist Circumference | From randomisation (week 0) to end of treatment (week 52) | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | centimeter (cm) | MEAN |
| SECONDARY | Change in Systolic Blood Pressure | From randomisation (week 0) to end of treatment (week 52) | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | millimeters of mercury (mmHg) | MEAN |
| SECONDARY | Change in Triglycerides (Millimoles Per Liter [mmol/L]) - Ratio to Baseline | From randomisation (week 0) to end of treatment (week 52) | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Ratio of triglycerides | GEOMETRIC_MEAN |
| SECONDARY | Change in Total Cholesterol (mmol/L) - Ratio to Baseline | From randomisation (week 0) to end of treatment (week 52) | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Ratio of total cholesterol | GEOMETRIC_MEAN |
| SECONDARY | Change in High Density Lipoprotein (HDL) Cholesterol (mmol/L) - Ratio to Baseline | From randomisation (week 0) to end of treatment (week 52) | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Ratio of HDL cholesterol | GEOMETRIC_MEAN |
| SECONDARY | Change in Low Density Lipoprotein (LDL) Cholesterol (mmol/L) - Ratio to Baseline | From randomisation (week 0) to end of treatment (week 52) | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Ratio of LDL cholesterol | GEOMETRIC_MEAN |
| SECONDARY | Change in Very Low Density Lipoprotein (VLDL) Cholesterol (mmol/L) - Ratio to Baseline | From randomisation (week 0) to end of treatment (week 52) | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Ratio of VLDL cholesterol | GEOMETRIC_MEAN |
| SECONDARY | Change in Body Weight (Kilogram [Kg]) | From randomisation (week 0) to week 52 | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | kilogram (Kg) | MEAN |
| SECONDARY | Participants Achieving Body Weight Reduction Greater Than or Equal (≥) 5% (Yes/No) | At week 52 | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Participants Achieving Body Weight Reduction Greater Than or Equal (≥) 10% (Yes/No) | At week 52 | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Participants Achieving Body Weight Reduction Greater Than or Equal (≥) 15% (Yes/No) | At week 52 | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Participants Achieving Body Weight Reduction Greater Than or Equal (≥) 20% (Yes/No) | At week 52 | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Change in Pulse | From randomisation (week 0) to end of treatment (week 52) | FAS included all randomised participants. 'Overall Number of Participants Analysed' = participants with available data. | beats per minute (bpm) | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05040971/outcomes